Trials / Completed
CompletedNCT07285772
Clinical Performance of Various Bilayer Biomimetic Resin Composite Strategies
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Tanta University · Academic / Other
- Sex
- All
- Age
- 35 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to evaluate several bilayer biomimetic composite resin techniques in class I cavities over the course of 18 months in a randomized, double-blind clinical trial.
Detailed description
To make resin composite restorations more resistant to cracking in cavities that are under a lot of stress, some have proposed using fiber reinforcement. This proposal is supported by numerous prior investigations that have demonstrated the efficacy of these repairs. By adjusting their orientation, fibers can control the pressures brought on by polymerization shrinkage. Therefore, marginal microleakage has been reduced in comparison to conventional resin composites. One way the material's fibers improve its structural characteristics is by preventing cracks from propagating. Composites are ideal for direct restorations of large cavities in healthy teeth and teeth that have had endodontic treatment because the fiber structure improves their mechanical properties. Moreover, in 2021, a comprehensive analysis of research found that resin composite restorations reinforced with fibers had better adaptability and higher fracture resistance than the standard ones.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | short fiber reinforced composite , long fiber reinforced composite, light cure glass, flowable composite | All patients received four various bilayer biomimetic restorations in four groups (n = 40) as follows: Group I: short fiber reinforced composite (everX Posterior); ); Group II: long fiber reinforced composite (Ribbond Inc., USA); Group III: glass ionomer restorative materials (Riva SDI); and Group IV: flowable composite (G-aenial universal). |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2025-10-10
- Completion
- 2025-10-10
- First posted
- 2025-12-16
- Last updated
- 2025-12-16
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07285772. Inclusion in this directory is not an endorsement.